Literature DB >> 1982293

Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response.

I Elovaara1, E Poutiainen, R Raininko, L Valanne, A Virta, S L Valle, J Lähdevirta, M Iivanainen.   

Abstract

Brain MRI and/or CT were performed on 72 HIV-infected patients at various stages of the disease, and on 34 controls. The neuroradiological findings were related to duration of the infection, neurological symptoms, and cognitive abnormalities as well as to immunological findings in the CSF and blood. All types of brain atrophy were more severe and more frequent in HIV-infected subjects than in controls. Patients with neurological symptoms, those with advanced HIV infection, and patients with a duration of HIV infection of more than 4 years showed the most severe and most frequent neuroradiological abnormalities, including central and cortical atrophy, brain stem atrophy, and cerebellar atrophy. Subjects with cognitive defects exhibited more severe central atrophy than cognitively intact patients. However, slight brain atrophy and/or parenchymal lesions were found in 57% of cognitively intact HIV-seropositive individuals. Patients with brain atrophy and those with radiologically normal brain, both showed increased intrathecal synthesis of total IgG, and intrathecal HIV-antibody synthesis. However, a declined general immune response and a lowered CSF leukocyte count were seen predominantly in patients with brain atrophy. The results suggest that subcortical, neurologically "silent" areas of brain white matter are an early target of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982293     DOI: 10.1016/0022-510x(90)90149-h

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

Authors:  D López-Villegas; R E Lenkinski; I Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter.

Authors:  Kalpana J Kallianpur; Cecilia Shikuma; Gregory R Kirk; Bruce Shiramizu; Victor Valcour; Dominic Chow; Scott Souza; Beau Nakamoto; Napapon Sailasuta
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

Review 6.  Recent advances in the neurology of HIV infection.

Authors:  R K Petty
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

7.  Plasma cytokine levels are related to brain volumes in HIV-infected individuals.

Authors:  Assawin Gongvatana; Stephen Correia; Shira Dunsiger; Lynne Gauthier; Kathryn N Devlin; Skye Ross; Bradford Navia; Karen T Tashima; Suzanne DeLaMonte; Ronald A Cohen
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-02       Impact factor: 4.147

8.  Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume.

Authors:  Yulin Ge; Dennis L Kolson; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

9.  Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Authors:  Anika Guha; Matthew R Brier; Mario Ortega; Elizabeth Westerhaus; Brittany Nelson; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

10.  Is intracranial atherosclerosis an independent risk factor for cerebral atrophy? A retrospective evaluation.

Authors:  S Erbay; R Han; M Aftab; Kelly H Zou; J F Polak; Rafeeque A Bhadelia
Journal:  BMC Neurol       Date:  2008-12-22       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.